Literature DB >> 18610474

Carvedilol tratment of chronic heart failure: a new era.

M Bristow.   

Abstract

Entities:  

Year:  1998        PMID： 18610474      PMCID： PMC1766491          DOI： 10.1136/hrt.79.2008.31s

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  29 in total

Review 1.  Beta-adrenergic function in heart muscle disease and heart failure.

Authors:  M R Bristow; N E Kantrowitz; R Ginsburg; M B Fowler
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

2.  Identification of alpha 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein.

Authors:  T Vago; M Bevilacqua; G Norbiato; G Baldi; E Chebat; P Bertora; G Baroldi; R Accinni
Journal:  Circ Res       Date:  1989-03       Impact factor: 17.367

3.  Pharmacology of bucindolol in isolated canine vascular smooth muscle.

Authors:  T J Rimele; L L Aarhus; R R Lorenz; T W Rooke; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

4.  Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade.

Authors:  S A Hall; C G Cigarroa; L Marcoux; R C Risser; P A Grayburn; E J Eichhorn
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

5.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

6.  Receptor pharmacology of carvedilol in the human heart.

Authors:  M R Bristow; P Larrabee; W Minobe; R Roden; L Skerl; J Klein; D Handwerger; J D Port; B Müller-Beckmann
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

7.  Reduced beta 1 receptor messenger RNA abundance in the failing human heart.

Authors:  M R Bristow; W A Minobe; M V Raynolds; J D Port; R Rasmussen; P E Ray; A M Feldman
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.

Authors:  S L Olsen; E M Gilbert; D G Renlund; D O Taylor; F D Yanowitz; M R Bristow
Journal:  J Am Coll Cardiol       Date:  1995-05       Impact factor: 24.094

9.  Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.

Authors:  M R Bristow; J B O'Connell; E M Gilbert; W J French; G Leatherman; N E Kantrowitz; J Orie; M L Smucker; G Marshall; P Kelly
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

10.  Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.

Authors:  E M Gilbert; J L Anderson; D Deitchman; F G Yanowitz; J B O'Connell; D G Renlund; M Bartholomew; P C Mealey; P Larrabee; M R Bristow
Journal:  Am J Med       Date:  1990-03       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.